Search Result "hyperprolactinemia."

Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics

Journal: Reviews on Recent Clinical Trials
Volume: 6 Issue: 1 Year: 2011 Page: 52-64
Author(s): Walter Milano, Cosimo Walter DAcunto, Michele De Rosa, Michela Festa, Luca Milano, Claudio Petrella, Anna Capasso

Screening Models For Neuroleptic Drug-Induced Hyperprolactinemia: A Mini-Review

Ebook: Personalized Immunotherapy for Tumor Diseases and Beyond

Volume: 8 Year: 2020
Author(s): Prashant Tiwari,Sunil Kumar Dubey,Shweta Shrivastava,Pratap Kumar Sahu
Doi: 10.2174/97898114700801200801
Case Studies

Hyperprolactinemia Secondary to Pituitary Microadenoma Versus Haloperidol- A Diagnostic Enigma. A Case Report and Brief Review

Journal: Current Drug Safety
Volume: 12 Issue: 1 Year: 2017 Page: 19-21
Author(s): Subramoniam Madhusoodanan,Leah R. Steinberg,Alisa Coleman,Samuel Bavli

Treatment of Antipsychotic-Induced Hyperprolactinemia: An Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8 Issue: 1 Year: 2014 Page: 30-37
Author(s): Domenico De Berardis,Michele Fornaro,Nicola Serroni,Stefano Marini,Monica Piersanti,Marilde Cavuto,Alessandro Valchera,Monica Mazza,Gabriella Girinelli,Felice Iasevoli,Giampaolo Perna,Giovanni Martinotti,Massimo Di Giannantonio

General Research Article

Different Cabergoline Effect on Metabolic and Anthropometric Parameters in Female Prolactinoma Patients Versus Idiopathic Hyperprolactinemia Patients

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19 Issue: 4 Year: 2019 Page: 511-518
Author(s): Mohamed M. Aboelnaga,Eman H. Eladawy,Maha M. Elshafei,Nahed Abdullah,Moustafa El Shaer

Review Article

Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 17 Issue: 1 Year: 2017 Page: 38-55
Author(s): Walter Milano, Chiara Colletti, Anna Capasso

Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia:The Role of Partial Agonists of D2 Dopaminergic Receptors

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 4 Issue: 3 Year: 2010 Page: 230-240
Author(s): Domenico De Berardis, Tiziano Acciavatti, Daniela Campanella, Nicola Serroni, Luigi Olivieri, Carla Ranalli, Viviana Marasco, Alessandro Carano, Marilde Cavuto, Giuseppe Di Iorio, Monica Piersanti, Francesco S. Moschetta, Massimo Di Giannantonio

Research Article

Prolactin Induces IL-2 Associated TRAIL Expression on Natural Killer Cells from Chronic Hepatitis C Patients In vivo and In vitro

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19 Issue: 7 Year: 2019 Page: 975-984
Author(s): Maria L.H. Medel,Gabriela G. Reyes,Luz M. Porras,Arturo R. Bernal,Jesús S. Luna,Adolfo P. Garcia,Jacqueline Cordova,Adalberto Parra,Srinivas Mummidi,David Kershenobich,Joselín Hernández

Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs

Journal: Current Neuropharmacology
Volume: 3 Issue: 1 Year: 2005 Page: 73-85
Author(s): W. Aichhorn, M. Gasser, E. M. Weiss, C. Adlassnig, J. Marksteiner

Systematic Review Article

Risks Associated with Vortioxetine in the Established Therapeutic Indication

Journal: Current Neuropharmacology
Volume: 19 Issue: 5 Year: 2021 Page: 723-729
Author(s): Akansha Verma,Anoop Kumar

Previous   Next

Go To   Results 1 - 1 of 174

Filter Result

Volume Year
Content Type
© 2024 Bentham Science Publishers | Privacy Policy